Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 11Unknown 4Terminated 3Recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Leukemia, Myeloid, Acute 8Myelodysplastic Syndromes 5Leukemia 5Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Chronic-Phase 4Lymphoma, Large B-Cell, Diffuse 3Lymphoma 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Recurrence 2Primary Myelofibrosis 2Neoplasms, Plasma Cell 2Myeloproliferative Disorders 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Chronic 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Lymphocytic, Chronic, B-Cell 2Hodgkin Disease 2Hematologic Neoplasms 2Hematologic Diseases 2Congenital Abnormalities 2Burkitt Lymphoma 2Waldenstrom Macroglobulinemia 1Thrombocythemia, Essential 1Testicular Neoplasms 1Testicular Germ Cell Tumor 1Small Cell Lung Carcinoma 1Sarcoma, Ewing 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Isotretinoin 3imetelstat 2Peripheral Blood Stem Cell Transplantation 2Cyclophosphamide 2thymoglobulin 1pazopanib 1naxitamab 1lorukafusp alfa 1liposomal doxorubicin 1keyhole-limpet hemocyanin 1fludarabine phosphate 1fludarabine 1defibrotide 1arginyllysine 1Whole-Body Irradiation 1Whole Body Imaging 1Vincristine 1Vaccines 1Tretinoin 1Topotecan 1Thiotepa 1Therapeutics 1Temozolomide 1Tacrolimus 1Stem Cell Transplantation 1Spermine Synthase 1Specimen Handling 1Radiotherapy 1Radiation 1Pentetic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Neuroblastoma × Busulfan × Clear all
NCT00874315 2015-10-16

Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed or Refractory High-Risk NBL.

Nationwide Children's Hospital

Phase 2 Withdrawn
CNS

Neuroblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡